Gabapentin and Neural Mobilization Pain Reduction Effect Compared to Only Gabapentine
Launched by UNIVERSIDAD EUROPEA DE MADRID · Jan 15, 2025
Trial Information
Current as of June 17, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well a combination of a physiotherapy technique and the medication gabapentin can reduce pain in people with carpal tunnel syndrome, compared to using gabapentin alone. Carpal tunnel syndrome is a condition that affects the wrist, causing pain, numbness, and tingling, often due to pressure on the median nerve. The researchers want to find out if adding physiotherapy can help patients feel better than just taking the medication.
To participate in this trial, individuals must be between the ages of 65 and 74, have a doctor’s diagnosis of carpal tunnel syndrome confirmed by specific tests, and be able to understand Spanish. They also need to show certain signs of the condition and agree to join the study. Participants will receive either the combined treatment or only gabapentin and will be monitored throughout the trial to see how their pain changes. It's important to note that people with certain health issues or who are currently receiving other pain treatments cannot join this study. This trial is currently looking for participants, so if you or someone you know might be interested, it could be a great opportunity to help improve treatment for carpal tunnel syndrome.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants must be medically diagnosed with unilateral carpal tunnel syndrome (with confirmative electrodiagnostic findings).
- • Full understanding of written and spoken Spanish (language).
- • Participants must freely consent to participate.
- • The presence of positive Phalen an Tinel sings.
- • The presence of carpal tunnel syndrome signs and symptoms
- Exclusion Criteria:
- • The lack to meet inclusion criterions, the presence of cognitive impairment, tumors, cancer, recent (affected) upper limb surgery or trauma, pregnancy, kinesiophobia, deformities of the (affected) upper limb, recent skin injuries or infections (in the affected upper limb), autoimmune inflammatory conditions or flu type symptoms, allergy to gabapentin, allergy to ibuprofen arginine, and also: participants must not be (during the present investigation) under any type of pain reducing treatment (conservative, homeopathic, invasive or not invasive)
About Universidad Europea De Madrid
Universidad Europea de Madrid (UEM) is a leading academic institution dedicated to advancing research and education in various fields, including health sciences. As a clinical trial sponsor, UEM is committed to fostering innovative research that contributes to the understanding and improvement of medical practices. The university collaborates with healthcare professionals and researchers to design and implement rigorous clinical trials, ensuring adherence to ethical standards and regulatory guidelines. UEM's focus on interdisciplinary collaboration and cutting-edge research methodologies positions it as a pivotal player in the advancement of clinical knowledge and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, Carabobo, Venezuela
Patients applied
Trial Officials
Francisco Unda, PhD
Principal Investigator
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported